nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antithrombotic Agents in Coronary Artery Disease
|
Cairns, John A. |
|
2001 |
119 |
1S |
p. 228S-252S nvt p. |
artikel |
2 |
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
|
Albers, Gregory W. |
|
2001 |
119 |
1S |
p. 300S-320S nvt p. |
artikel |
3 |
Antithrombotic Therapy for Venous Thromboembolic Disease
|
Hyers, Thomas M. |
|
2001 |
119 |
1S |
p. 176S-193S nvt p. |
artikel |
4 |
Antithrombotic Therapy in Atrial Fibrillation
|
Albers, Gregory W. |
|
2001 |
119 |
1S |
p. 194S-206S nvt p. |
artikel |
5 |
Antithrombotic Therapy in Children
|
Monagle, Paul |
|
2001 |
119 |
1S |
p. 344S-370S nvt p. |
artikel |
6 |
Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
|
Popma, Jeffrey J. |
|
2001 |
119 |
1S |
p. 321S-336S nvt p. |
artikel |
7 |
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
|
Stein, Paul D. |
|
2001 |
119 |
1S |
p. 220S-227S nvt p. |
artikel |
8 |
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
|
Stein, Paul D. |
|
2001 |
119 |
1S |
p. 278S-282S nvt p. |
artikel |
9 |
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
|
Jackson, Mark R. |
|
2001 |
119 |
1S |
p. 283S-299S nvt p. |
artikel |
10 |
Antithrombotic Therapy in Valvular Heart Disease
|
Salem, Deeb N. |
|
2001 |
119 |
1S |
p. 207S-219S nvt p. |
artikel |
11 |
Grades of Recommendation for Antithrombotic Agents
|
Guyatt, Gordon |
|
2001 |
119 |
1S |
p. 3S-7S nvt p. |
artikel |
12 |
Hemorrhagic Complications of Anticoagulant Treatment
|
Levine, Mark N. |
|
2001 |
119 |
1S |
p. 108S-121S nvt p. |
artikel |
13 |
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
|
Hirsh, Jack |
|
2001 |
119 |
1S |
p. 64S-94S nvt p. |
artikel |
14 |
Intravenous Thrombolysis in Acute Myocardial Infarction
|
Ohman, E. Magnus |
|
2001 |
119 |
1S |
p. 253S-277S nvt p. |
artikel |
15 |
Managing Oral Anticoagulant Therapy
|
Ansell, Jack |
|
2001 |
119 |
1S |
p. 22S-38S nvt p. |
artikel |
16 |
Medicolegal Implications of the Consensus Conference
|
McIntyre, Kevin |
|
2001 |
119 |
1S |
p. 337S-343S nvt p. |
artikel |
17 |
New Anticoagulant Drugs
|
Weitz, Jeffrey I. |
|
2001 |
119 |
1S |
p. 95S-107S nvt p. |
artikel |
18 |
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
|
Hirsh, Jack |
|
2001 |
119 |
1S |
p. 8S-21S nvt p. |
artikel |
19 |
Platelet-Active Drugs
|
Patrono, Carlo |
|
2001 |
119 |
1S |
p. 39S-63S nvt p. |
artikel |
20 |
Prevention of Venous Thromboembolism
|
Geerts, William H. |
|
2001 |
119 |
1S |
p. 132S-175S nvt p. |
artikel |
21 |
The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis
|
Hirsh, Jack |
|
2001 |
119 |
1S |
p. 1S-2S nvt p. |
artikel |
22 |
Use of Antithrombotic Agents During Pregnancy
|
Ginsberg, Jeffrey S. |
|
2001 |
119 |
1S |
p. 122S-131S nvt p. |
artikel |